The ministry stated the move should “ensure greater speed in identifying the virus, […] under surveillance since it was first detected in the country, in June 2022.”
Factors included the epidemiological situation, the limited laboratory response, tests withheld, the risks of delayed diagnosis, and the need to decentralize testing.
The National Health Surveillance Agency (ANVISA) approved the registration of a rapid Zika test Monday (Feb. 15). The product, provided by Canada-based BioCAN Diagnostics laboratory, takes 20 minutes to detect if the patient has been infected Zika.